Role of serotonin in gastrointestinal motility and irritable bowel syndrome

Tyce, 1985, Biochemistry of serotonin, 1 Gershon, 1965, Serotonin: synthesis and release from the myenteric plexus of the mouse intestine, Science, 149, 197, 10.1126/science.149.3680.197 Yu, 1999, Immunohistochemical localization of tryptophan hydroxylase in the human and rat gastrointestinal tracts, J Comp Neurol, 411, 654, 10.1002/(SICI)1096-9861(19990906)411:4<654::AID-CNE9>3.0.CO;2-H Gershon, 2007, The serotonin signaling system: from basic understanding to drug development for functional GI disorders, Gastroenterology, 132, 397, 10.1053/j.gastro.2006.11.002 Walther, 2003, Synthesis of serotonin by a second tryptophan hydroxylase isoform, Science, 299, 76, 10.1126/science.1078197 Cote, 2003, Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function, Proc Natl Acad Sci USA, 100, 13525, 10.1073/pnas.2233056100 Tamir, 1985, Human serotonectin: a blood glycoprotein that binds serotonin and is associated with platelets and white blood cells, J Cell Sci, 73, 187, 10.1242/jcs.73.1.187 Wade, 1996, Localization and function of a 5-HT transporter in crypt epithelia of the gastrointestinal tract, J Neurosci, 16, 2352, 10.1523/JNEUROSCI.16-07-02352.1996 Gershon, 1999, Review article: Roles played by 5-hydroxytryptamine in the physiology of the bowel, Aliment Pharmacol Ther, 13, 15, 10.1046/j.1365-2036.1999.00002.x-i2 Wade, 1994, Analysis of the role of 5-HT in the enteric nervous system using anti-idiotypic antibodies to 5-HT receptors, Am J Physiol, 266, G403 Zhou, 1999, Synaptic activation and properties of 5-hydroxytryptamine (3) receptors in myenteric neurons of guinea pig intestine, J Pharmacol Exp Ther, 290, 803 Gershon, 1994, 5-hydroxytryptamine and enteric neurons. In: Fozard J.R., ed. Peripheral actions of 5-hydroxytryptamine (serotonin), Pharmacol Ther, 62, 159 Mawe, 1993, The 5-HT1P receptor, Drug News Persp, 6, 24 Bülbring, 1967, 5-Hydroxytryptamine participation in the vagal inhibitory innervation of the stomach, J Physiol, 192, 823, 10.1113/jphysiol.1967.sp008334 Bulbring, 1959, The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa, J Physiol (Lond), 146, 18, 10.1113/jphysiol.1959.sp006175 Bulbring, 1958, Observations concerning the action of 5-hydroxytryptamine on the peristaltic reflex, Br J Pharmacol, 13, 4 Sugiuar, 2004, TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation, J Neurosci, 24, 9521, 10.1523/JNEUROSCI.2639-04.2004 Grundy, 1994, Role of 5-hydroxytryptamine in gastrointestinal chemosensitivity, Dig Dis Sci, 39, S44, 10.1007/BF02300369 Kirchgessner, 1996, In situ identification and visualization of neurons that mediate enteric and enteropancreatic reflexes, J Comp Neurol, 371, 270, 10.1002/(SICI)1096-9861(19960722)371:2<270::AID-CNE7>3.0.CO;2-# Pan, 2000, Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine, J Neurosci, 20, 3295, 10.1523/JNEUROSCI.20-09-03295.2000 Cooke, 1997, 5-HT activates neural reflexes regulating secretion in the guinea-pig colon, Neurogastroenterol Motil, 9, 181, 10.1046/j.1365-2982.1997.d01-41.x Kim, 2001, D-glucose releases 5-hydroxytryptamine from human BON cells as a model of enterochromaffin cells, Gastroenterology, 121, 1400, 10.1053/gast.2001.29567 Bertrand PP, Furness JB and Bornstein JC. 5-HT and ATP stimulate the mucosal terminals of some myenteric sensory neurons and cause increases in excitability in a population of sensory neurons. Falk Symposium No. 112. Neurogastroenterology — from the basics to the clinics (1999) Freiburg, Germany. Gershon, 2004, Review article: serotonin receptors and transporters—roles in normal and abnormal gastrointestinal motility, Aliment Pharmacol Ther, 20, 3, 10.1111/j.1365-2036.2004.02180.x Chen, 1998, Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception, Am J Physiol, 275, G433 Coote, 1974, The influence of bulbospinal monoaminergic pathways on sympathetic nerve activity, J Physiol (Lond), 241, 453, 10.1113/jphysiol.1974.sp010666 Richardson, 1985, Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs, Nature, 316, 126, 10.1038/316126a0 Donowitz, 1977, Effect of serotonin treatment on intestinal transport in the rabbit, Am J Physiol, 232, 85 Siriwardena, 1993, A 5-HT receptor mediates serotonin-induced electrolyte transport in rat left colon, J Surg Res, 55, 323, 10.1006/jsre.1993.1149 Nilsson, 1983, 5-Hydroxytryptamine and cholera secretion: a histochemical and physiological study in cat, Gut, 24, 542, 10.1136/gut.24.6.542 Lundgren, 1998, 5-Hydroxytryptamine, enterotoxins, and intestinal fluid secretion, Gastroenterology, 115, 1009, 10.1016/S0016-5085(98)70275-6 Peregrin, 1999, Involvement of serotonin and calcium channels in the intestinal fluid secretion evoked by bile salt and cholera toxin, Br J Pharmacol, 127, 887, 10.1038/sj.bjp.0702615 Sjoqvist, 1992, Actions of serotonin antagonists on cholera-toxin-induced intestinal fluid secretion, Acta Physiol Scand, 145, 229, 10.1111/j.1748-1716.1992.tb09360.x Peart, 1961, The effect of a serotonin antagonist (UML 491) in carcinoid disease, Lancet, ii, 1172, 10.1016/S0140-6736(61)90846-7 Gustafsen, 1986, Ketanserin versus placebo in carcinoid syndrome. A clinical controlled trial, Scand J Gastroenterol, 21, 816, 10.3109/00365528609011123 Anderson, 1987, Remission of symptoms in carcinoid syndrome with a new 5-hydroxytryptamine M receptor antagonist, Br Med J, 294, 1129, 10.1136/bmj.294.6580.1129 Bearcroft, 1998, Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study, Gut, 42, 42, 10.1136/gut.42.1.42 Houghton, 2003, Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome, Gut, 52, 663, 10.1136/gut.52.5.663 Dunlop, 2005, Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome, Clin Gastroenterol Hepatol, 3, 349, 10.1016/S1542-3565(04)00726-8 Atkinson, 2006, Altered 5-hydroxytryptamine signaling in patients with constipation-and diarrhea-predominant irritable bowel syndrome, Gastroenterology, 130, 34, 10.1053/j.gastro.2005.09.031 Barnes, 1999, A review of central 5-HT receptors and their function, Neuropharmacology, 38, 1083, 10.1016/S0028-3908(99)00010-6 Airaksinen, 1965, Glucuronidation of 5-hydroxyindole derivatives in vitro, Biochem Pharmacol, 14, 1019, 10.1016/0006-2952(65)90254-6 Tonini, 1995, Serotonin modulation of gastrointestinal motility, 53 Briejer, 1995, Gastrointestinal prokinetic benzamides: the pharmacology underlying stimulation of motility, Pharmacol Rev, 47, 631 Read, 1994, The importance of 5-hydroxytryptamine receptors in the gut, Pharmacol Ther, 62, 159, 10.1016/0163-7258(94)90009-4 Galligan, 1995, Electrophysiological studies of 5-hydroxytryptamine receptors on enteric neurons, 109 Prins, 1999, Evidence for 5-HT7 receptors mediating relaxation of human colonic circular smooth muscle, Br J Pharmacol, 128, 849, 10.1038/sj.bjp.0702762 Dietrich, 1996, 5-HT1A receptor-mediated inhibition of acetylcholine release from guinea pig myenteric plexus: potential mechanisms, Neuropharmacology, 35, 483, 10.1016/0028-3908(95)00197-2 Kuemmerle, 1995, Coexpression of 5-HT2A and 5-HT4 receptors coupled to distinct signaling pathways in human intestinal muscle cells, Gastroenterology, 109, 1791, 10.1016/0016-5085(95)90745-9 Derkach, 1989, 5-HT3 receptors are membrane ion channels, Nature, 339, 706, 10.1038/339706a0 Von der Ohe, 1994, Serotonergic mediation of postprandial colonic tone and phasic responses in man, Gut, 35, 536, 10.1136/gut.35.4.536 Scolapio, 1995, Ascending colon response to feeding: evidence for a 5-hydroxytryptamine-3 mechanism, Scand J Gastroenterol, 30, 562, 10.3109/00365529509089790 Von de Ohe, 1994, A 5-HT antagonists corrects the postprandial colonic hypertonic response in carcinoid diarrhea, Gastroenterology, 106, 1184, 10.1016/0016-5085(94)90008-6 Furness, 1999, Nutrient tasting and signaling mechanisms in the gut II. The intestine as a sensor organ: neural, endocrine, and immune response, Am J Physiol, 277, G922 Grider, 1996, 5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1P receptors on sensory CGRP neurons, Am J Physiol, 270, G778 Kadowaki, 1996, Participation of 5-HT4 and nicotinic receptors in the peristaltic reflex of guinea pig distal colon, Am J Physiol, 271, G849 Gershon, 2007, Serotonin and neuroprotection in functional bowel disorders, Neurogastroenterol Motil, 19, 19, 10.1111/j.1365-2982.2007.00962.x Tuladhar, 1996, 5-HT3 and 5-HT4 receptor-mediated facilitation of the emptying phase of the peristaltic reflex in the marmoset isolated ileum, Br J Pharmacol, 117, 1679, 10.1111/j.1476-5381.1996.tb15339.x Tuladhar, 1997, Evidence for a 5-HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum, Br J Pharmacol, 122, 1174, 10.1038/sj.bjp.0701503 Burks, 1994, Neurotransmission and neurotransmitters, 211 Blakely, 1991, Cloning and expression of a functional serotonin transporter from rat brain, Nature, 354, 66, 10.1038/354066a0 Blakely, 2005, Biogenic amine neurotransmitter transporters: just when you thought you knew them, Physiology (Bethesda), 20, 225, 10.1152/physiol.00013.2005 Chen, 2001, Maintenance of serotonin in the intestinal mucosa and ganglia of mice that lack the high-affinity serotonin transporter (SERT): abnormal intestinal motility and the expression of cation transporters, J Neurosci, 21, 6348, 10.1523/JNEUROSCI.21-16-06348.2001 Coates, 2004, Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome, Gastroenterology, 126, 1657, 10.1053/j.gastro.2004.03.013 Da Prada, 1972, Storage of 5-hydroxytryptamine in human blood platelets, Experientia, 28, 1328, 10.1007/BF01965326 Gershon, 1979, Uptake and release of 5-hydroxytryptamine by enteric 5-hydroxytryptaminergic neurones: effects of fluoxetine (Lilly 110140) and chlorimipramine, Br J Pharmacol, 66, 7, 10.1111/j.1476-5381.1979.tb16089.x Linden, 2003, Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis, Am J Physiol Gastrointest Liver Physiol, 285, G207, 10.1152/ajpgi.00488.2002 Li, 2000, Reduction in the density and expression, but not G-protein coupling, of serotonin receptors (5-HT1A) in 5-HT transporter knock-out mice: gender and brain region differences, J Neurosci, 20, 7888, 10.1523/JNEUROSCI.20-21-07888.2000 Li, 2003, Brain region specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice, J Neurochem, 84, 1256, 10.1046/j.1471-4159.2003.01607.x Liu, 2002, Expression and function of 5-HT3 receptors in the enteric neurons of mice lacking the serotonin transporter, Am J Physiol, 283, G1398 Hahn, 1999, Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom, Digestion, 60, 77, 10.1159/000007593 Ragnarsson, 1999, Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples, Scand J Gastroenterol, 34, 993, 10.1080/003655299750025093 Hammer, 1999, Diagnostic criteria for the Irritable bowel syndrome, Am J Med, 107, 5S, 10.1016/S0002-9343(99)00276-4 Prior, 1990, Anorectal manometry in irritable bowel syndrome: differences between diarrhea and constipation predominant subjects, Gut, 31, 458, 10.1136/gut.31.4.458 Moskwa, 2007, Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome, Pol Merkur Lekarski, 22, 366 Sikander, 2007, Altered serotonin signaling in IBD, diarrhea-predominant IBS and Microscopic colitis, Indian J Gastoenterol, 26, A42 Dunlop, 2003, Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in post infectious IBS, Gastroenterology, 125, 1651, 10.1053/j.gastro.2003.09.028 Li, 2004, Morphological and functional alteration of serotonin-producing intestinal enterochromaff in cells in patients with irritable bowel syndrome, Zhonghua Xiaohua Zazhi, 24, 94 Jiang, 2005, Distribution feature of colonic 5-HT in irritable bowel syndrome, Shijie Huaren Xiaohua Zazhi, 13, 541 Wang, 2005, Comparison of intestinal mucosal monamine neurotransmitter of ulcerative colitis and irritable bowel syndrome, Zhonghua Neike Zazhi, 11, 851 El-Salhy, 1999, Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation, Scand J Gastroenterol, 34, 1007, 10.1080/003655299750025110 Zhao, 2000, Enterochromaffin and serotonin cells are abnormal for patients with colonic inertia, Dis Colon Rectum, 43, 858, 10.1007/BF02238027 Baig, 2002, Variability in serotonin and enterochromaffin cells in patients with colonic inertia and idiopathic diarrhoea as compared to normal controls, Colorectal Dis, 4, 348, 10.1046/j.1463-1318.2002.00404.x Spiller, 2000, Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome, Gut, 47, 804, 10.1136/gut.47.6.804 Bose, 2000, 5-Hydroxytryptamine and enterochromaffin cells in the irritable bowel syndrome, Gastroenterology, 118, A563, 10.1016/S0016-5085(00)84387-5 Kyosola, 1977, Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon, Scand J Gastroenterol, 12, 363, 10.3109/00365527709180942 Miwa, 2001, Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits, Digestion, 63, 188, 10.1159/000051888 Heils, 1996, Allelic variation of human serotonin transporter gene expression, J Neurochem, 66, 2621, 10.1046/j.1471-4159.1996.66062621.x Lesch, 1996, Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region, Science, 274, 1527, 10.1126/science.274.5292.1527 Stoltenberg, 2002, Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism, Am J Med Genet, 114, 230, 10.1002/ajmg.10187 Heitkemper, 2005, Association of SERT polymorphism with psychological distress, symptoms and predominant stool group in women with irritable bowel syndrome, Gastroenterology, 4, A59 Yeo, 2004, Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women, Gut, 53, 1452, 10.1136/gut.2003.035451 Pata, 2002, Serotonin transporter gene polymorphism in irritable bowel syndrome, Am J Gastroenterol, 97, 1780, 10.1111/j.1572-0241.2002.05841.x Li, 2007, The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients, Dig Dis Sci, 52, 2942, 10.1007/s10620-006-9679-y Wang, 2004, Serotonin transporter gene polymorphism in irritable bowel syndrome, Zhonghua Nei Ke Za Zhi, 43, 439 Camilleri, 2002, Serotonin-transporter polymorphism pharmacogenetics in diarrhea predominant irritable bowel syndrome, Gastroenterology, 123, 425, 10.1053/gast.2002.34780 Lee, 2004, Serotonin transporter gene polymorphism in healthy adults and patients with irritable bowel syndrome, Korean J Gastroenterol, 43, 18 Kim, 2004, Association of distinct alpha (2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders, Gut, 53, 829, 10.1136/gut.2003.030882 Park, 2006, Serotonin transporter gene polymorphism and irritable bowel syndrome, Neurogastroenterol Motil, 18, 995, 10.1111/j.1365-2982.2006.00829.x Saito, 2007, A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome, Neurogastroenterol Motil, 19, 465, 10.1111/j.1365-2982.2007.00905.x Niesler, 2007, SERT-P polymorphism in the serotonin transporter gene and irritable bowel syndrome: what's going on?, Gastroenterology, 132, A675 Van Kerkhoven, 2007, Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome, Aliment Pharmacol Ther, 26, 979, 10.1111/j.1365-2036.2007.03453.x Bellini, 2003, Platelet serotonin transporter in patients with diarrhea-predominant irritable bowel syndrome both before and after treatment with alosetron, Am J Gastroenterol, 98, 2705, 10.1111/j.1572-0241.2003.08669.x Blakely, 2000, Biogenic amine transporters: regulation in flux, Curr Opin Neurobiol, 10, 328, 10.1016/S0959-4388(00)00088-X Costall, 2004, 5-HT3 receptors, Curr Drug Targets CNS Neurol Disord, 3, 27, 10.2174/1568007043482624 Bockaert, 2004, 5-HT4 receptors, Curr Drug Targets CNS Neurol Disord, 3, 39, 10.2174/1568007043482615 Galligan, 2002, Ligand-gated ion channels in the enteric nervous system, Neurogastroenterol Motil, 14, 611, 10.1046/j.1365-2982.2002.00363.x Kozlowski, 2000, The 5-HT(3) receptor antagonist alosetron inhibits the colorectal distention induced depressor response and spinal c-fos expression in the anaesthetised rat, Gut, 46, 474, 10.1136/gut.46.4.474 Chang, 2006, Incidence of ischemic colitis and serious complications of constipation among patients using alosteron: systematic review of clinical trials and post-marketing surveillance data, Am J Gastroenterol, 101, 1069, 10.1111/j.1572-0241.2006.00459.x Liu, 2005, Expression and function of 5-HT4 receptors in the mouse enteric nervous system, Am J Physiol Gastrointest Liver Physiol, 289, G1148, 10.1152/ajpgi.00245.2005 Pasricha, 2007, Desperately seeking serotonin. A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders, Gastroenterology, 132, 2287, 10.1053/j.gastro.2007.04.057 Beattie, 2004, The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo, Br J Pharmacol, 143, 549, 10.1038/sj.bjp.0705929 Tonini, 2005, 5-HT(7) receptors modulate peristalsis and accommodation in the guinea pig ileum, Gastroenterology, 129, 1557, 10.1053/j.gastro.2005.08.005 Camilleri, 2007, Pharmacodynamic effects of a novel prokinetic 5-HT receptor agonist, ATI-7505, in humans, Neurogastroenterol Motil, 19, 30, 10.1111/j.1365-2982.2006.00865.x Evangelista, 2007, Drug evaluation: pumosetrag for the treatment of irritable bowel syndrome and gastroesophageal reflux disease, Curr Opin Investig Drugs, 8, 416 Camilleri, 2008, A placebo-controlled trial of prucalopride for severe chronic constipation, N Engl J Med, 29, 2344, 10.1056/NEJMoa0800670 Drossman, 1997, Irritable bowel syndrome: a technical review for practice guideline development, Gastroenterology, 112, 2120, 10.1053/gast.1997.v112.agast972120